Dr. Sunil Gupta, MD

Dr. Gupta practices at Retina Specialty Institute in Pensacola, Florida.

Dr. Gupta's NPI, 1063489383, was assigned on March 6, 2006. Dr. Gupta graduated from University Of Cincinnati College Of Medicine in 1988. Dr. Gupta holds Florida license ME66379.

Dr. Gupta's primary practice is Retina Specialty Institute, at 5150 N Davis Hwy, Pensacola, FL 32503-2030. The practice phone is (850) 476-6759.

Dr. Gupta's primary practice is Retina Specialty Institute in Pensacola, Florida. Dr. Gupta is also affiliated with Baptist Hospital. Dmand AI also links Dr. Gupta to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gupta practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Gupta's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Gupta is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Gupta's licenses on file in 15 states: Florida, Arizona, Georgia, Illinois, Louisiana, Michigan, North Carolina, New York, Pennsylvania, Washington, Alabama, Indiana, Ohio, Iowa and Texas.

Dmand AI lists age-related macular degeneration, cataract surgery with lens implant, eyelid inflammation, glaucoma, glaucoma surgery, hereditary corneal conditions, hypertensive retinopathy and inflammation of iris among the conditions Dr. Gupta treats.

CMS data shows 161,123 Medicare services from Dr. Gupta across 29 procedure codes in 2024, for 2,020 Medicare patients. Medicare paid $13,103,876 for them.

CMS counts 2,020 Medicare patients who saw Dr. Gupta in 2024. The largest group is 75 to 84, with 832 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gupta's median patient age at 74, with 56% women.

In 2024, Dr. Gupta wrote 1,495 Medicare Part D claims for 453 patients. 68% of them were for generic drugs. CMS names the drug for 1,363 of them, across 21 drugs with 11 or more claims each, at $86,120 in total drug cost. In 2023, CMS named 1,375 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gupta for performance year 2024, reported as part of a group. Dr. Gupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of cataract surgery by Dr. Gupta, more than 32% of the clinicians it reports for that procedure.

Dmand AI links 123 papers to Dr. Gupta, published from 2011 to 2025. 2024 was the busiest year, with 22. The most frequent topics are Endoscopic Mucosal Resection, Colonoscopy and Colonic Polyps. Dr. Gupta has published most often in Endoscopy. Dr. Gupta's most frequent co-authors are Varan Perananthan, Christopher Cao, MD and David S. Boyer, MD.

Dmand AI links Dr. Gupta to 3 clinical trials. Conditions studied include Macular Degeneration and Retinal Degeneration. Open Payments lists research payments to Dr. Gupta that name 2 trials.

CMS Open Payments shows 358 general payments to Dr. Gupta from 29 drug and device companies from 2016 to 2025. Ownership or investment make up the largest share, 72% of the total. US Retina LLC paid the most, $2,164,234. It also lists 32 research payments totaling $235,949 from 2016 to 2023, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Gupta.

Dr. Gupta graduated from University Of Cincinnati College Of Medicine in 1988. Dr. Gupta is a member of AAO.

Dr. Gupta is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.